Smartphone application for preventing depression: study protocol for a workplace randomised controlled trial

BMJ Open
Mark DeadySamuel Harvey

Abstract

Depression is the leading cause of life years lost due to disability. Appropriate prevention has the potential to reduce the incidence of new cases of depression, however, traditional prevention approaches face significant scalability issues. Prevention programmes delivered by via smartphone applications provide a potential solution. The workplace is an ideal setting to roll out this form of intervention, particularly among industries that are unlikely to access traditional health initiatives and whose workplace characteristics create accessibility and portability issues. The study aims to evaluate the effectiveness of a smartphone application designed to prevent depression and improve well-being. The effectiveness of the app as a universal, selective and indicated prevention tool will also be evaluated. A multicentre randomised controlled trial, to determine the effectiveness of the intervention compared with an active mood monitoring control in reducing depressive symptoms (primary outcome) and the prevalence of depression at 3 months, with secondary outcomes assessing well-being and work performance. Employees from a range of industries will be invited to participate. Participants with likely current depression at baseline w...Continue Reading

References

Feb 1, 1990·Psychological Medicine·S C NewmanR C Bland
Mar 1, 1995·Statistical Methods in Medical Research·A PicklesJ L Vázquez-Barquero
Jul 22, 1998·Respiration; International Review of Thoracic Diseases·G HoheiselA P Perruchoud
Sep 15, 2001·Journal of General Internal Medicine·K KroenkeJ B Williams
Nov 2, 2001·The British Journal of Psychiatry : the Journal of Mental Science·G AndrewsG Carter
Mar 11, 2003·Journal of Occupational and Environmental Medicine·Ronald C KesslerPhillip Wang
Sep 10, 2003·Depression and Anxiety·Kathryn M Connor, Jonathan R T Davidson
Sep 16, 2003·Clinical Psychology Review·Derek R HopkoGeorg H Eifert
Jan 27, 2004·BMJ : British Medical Journal·Helen ChristensenAnthony F Jorm
Apr 7, 2004·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Paul WaraichLorena Hsu
Jun 3, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Gavin AndrewsHelen Lapsley
Jun 3, 2004·JAMA : the Journal of the American Medical Association·Koen DemyttenaereUNKNOWN WHO World Mental Health Survey Consortium
Feb 3, 2005·The Journal of Nervous and Mental Disease·Pim CuijpersFilip Smit
Jul 7, 2005·Psychological Medicine·Jianli Wang
Dec 27, 2005·General Hospital Psychiatry·Alexandra MartinElmar Braehler
Jan 13, 2006·The Australian and New Zealand Journal of Psychiatry·Helen ChristensenAilsa Korten
Jul 14, 2006·Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53·Paula M BarrettMark Dadds
Sep 23, 2006·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Julian M SomersLorena Hsu
Mar 7, 2007·Annals of Internal Medicine·Kurt KroenkeBernd Löwe
May 15, 2007·Acta Psychiatrica Scandinavica·P CuijpersA van Straten
Aug 25, 2007·Annual Review of Clinical Psychology·Steven M SouthwickDennis S Charney
Aug 30, 2008·Journal of Affective Disorders·Kurt KroenkeAli H Mokdad
Mar 3, 2009·The British Journal of Psychiatry : the Journal of Mental Science·Samuel B HarveyMatthew Hotopf
Mar 27, 2009·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Tracy R G Gladstone, William R Beardslee
May 13, 2009·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Alberto Chiesa, Alessandro Serretti
May 29, 2009·Clinical Psychology & Psychotherapy·Marcantonio M Spada, Adrian Wells
Feb 26, 2010·Cognitive Behaviour Therapy·Gerhard Andersson, Pim Cuijpers
Mar 31, 2010·Journal of Consulting and Clinical Psychology·Stefan G HofmannDiana Oh
Jun 30, 2011·PloS One·Pim CuijpersGerhard Andersson
Oct 13, 2011·Journal of Mental Health·Virginia HarrisonVijaya Manicavasagar
Dec 21, 2011·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Laura ManeaDean McMillan
Jan 9, 2013·Annals of Internal Medicine·An-Wen ChanDavid Moher
May 15, 2013·General Hospital Psychiatry·Rüya-Daniela KocaleventElmar Brähler
Aug 7, 2013·Clinical Psychology & Psychotherapy·Matthew PriceKenneth J Ruggiero
Oct 22, 2013·JAMA : the Journal of the American Medical Association·UNKNOWN World Medical Association
Nov 19, 2013·Journal of Medical Internet Research·Tara DonkerHelen Christensen

❮ Previous
Next ❯

Citations

Jul 7, 2020·Psychological Medicine·Mark DeadySamuel B Harvey
Sep 20, 2020·International Journal of Environmental Research and Public Health·Daniel A J CollinsMark Deady
Jul 8, 2019·Journal of Affective Disorders·D A JohnstonM Deady
Aug 17, 2021·Behavioural and Cognitive Psychotherapy·Abby AizenstrosNikolaos Kazantzis
Oct 26, 2021·Occupational Medicine·M DeadyS B Harvey

❮ Previous
Next ❯

Software Mentioned

Google Play
iTunes
R package simR
MMRM

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.